Kiadis Pharma NV (XAMS:KDS) Accumulated Depreciation : €-4.99 Mil (As of Dec. 2020)

View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Kiadis Pharma NV's quarterly accumulated depreciation increased from Dec. 2019 (€-4.09 Mil) to Jun. 2020 (€-4.68 Mil) and increased from Jun. 2020 (€-4.68 Mil) to Dec. 2020 (€-4.99 Mil).

Kiadis Pharma NV's annual accumulated depreciation increased from Dec. 2018 (€-1.98 Mil) to Dec. 2019 (€-4.09 Mil) and increased from Dec. 2019 (€-4.09 Mil) to Dec. 2020 (€-4.99 Mil).

Kiadis Pharma NV Accumulated Depreciation Historical Data

The historical data trend for Kiadis Pharma NV's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Accumulated Depreciation Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Accumulated Depreciation

Get a 7-Day Free Trial

-0.84

-1.02

-1.98

-4.09

-4.99

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Accumulated Depreciation	Get a 7-Day Free Trial											-1.98	-2.65	-4.09	-4.68	-4.99

Kiadis Pharma NV Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Kiadis Pharma NV Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (XAMS:KDS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (XAMS:KDS) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (XAMS:KDS) Headlines

No Headlines